VAERS 2026244
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6209
- Staat
- MI
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 11.01.2022
- Impfdatum
- 10.03.2021
- Beginn
- 24.12.2021
- Tage bis Beginn
- 289,0
- Dosis
- 2
- Route/Site
- IM / AR
Symptomtext
Patient is now deceased (12.30.21); Hospitalized (12.24.21); COVID-19 positive (12.23.21); Fully vaccinated Admission Date: 12/24/2021 Date of Death: 12/30/21 Time of Death: 4:30 PM Preliminary Cause of Death: COVID-19 virus infection DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 83 y.o. male with past medical history significant for B-cell lymphoma recently on chemotherapy (opted to forego the last treatment due to side effects), previous pleural effusions attributed to B-cell lymphoma which required drainage, chronic diastolic heart failure, coronary artery disease, persistent atrial fibrillation, recurrent DVTs, hypothyroidism, pulmonary fibrosis, BPH who presented for this hospitalization with worsening cough and shortness of breath for the past several days, most likely symptom onset sometime between 12/15-12/20 and has been diagnosed with COVID-19 pneumonia. In the ED, chest x-ray showed interval decrease in lung aeration with worsening bilateral airspace disease consistent with COVID-19 pneumonia. Patient was requiring 5 L oxygen via nasal cannula on admission. Oxygen requirements worsened, and patient was broadened on steroids to 40mg IV solu-medrol bid. D-dimer increased to 13,000 and then 23,000. CTA negative for PE but positive for consolidating airspace disease. Bilateral dopplers negative for DVTs. Continued on Xarelto, started on HAP treatment on 12/27 with Vancomycin and Cefepime, planned for 7 day course. Also started additional diuresis with 40mg IV lasix bid (up from home regimen of 40mg PO bid). Pulmonology was consulted early in hospital course had multiple goals discussions with patient. Patient worsened and family was adamant that he could not be intubated. He was changed to Comfort measures and passed on 12/30/2021 at 1630
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 12.13.21 - Cardiology appointment 12.15.21 - Pulmonology appointment 12.15.21 - PET scan concerning for pneumonia + effusions (difficulty breathing)
- Vorgeschichte
- OSA (obstructive sleep apnea) Cough Bronchiectasis Persistent atrial fibrillation Chronic anticoagulation Unspecified venous (peripheral) insufficiency History of deep venous thrombosis Non-rheumatic mitral valve disease Chronic diastolic congestive heart failure Renal insufficiency Anomalous left coronary artery CAD in native artery Need for SBE (subacute bacterial endocarditis) prophylaxis Atrial flutter Recurrent deep vein thrombosis (DVT) BiPAP (biphasic positive airway pressure) dependence Nonrheumatic aortic valve stenosis Shortness of breath Idiopathic pulmonary fibrosis B-cell lymphoma Complete heart block Cardiac pacemaker in situ Dizziness Pleural effusion
- Andere Medikamente
- acyclovir (ZOVIRAX) 400 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler atorvastatin (LIPITOR) 40 MG tablet benzonatate (TESSALON) 200 MG capsule cholecalciferol (VITAMIN D) 1000 units dexamet
- Allergien
- Fish AllergyAnaphylaxis SeafoodAnaphylaxis IodineRash Latex Penicillin V Potassium [Penicillin V]Rash Sm Povidone-iodine [Povidone Iodine]Rash
- Vorherige Impfungen
- -